Nonanticoagulant heparin inhibits NF-kappaB activation and attenuates myocardial reperfusion injury. - Wikidata - wikimedia - TriplyDB

Nonanticoagulant heparin inhibits NF-kappaB activation and attenuates myocardial reperfusion injury.

Nonanticoagulant heparin inhibits NF-kappaB activation and attenuates myocardial reperfusion injury.

http://www.wikidata.org/entity/Q31393590

about

Regulation of IkappaBalpha function and NF-kappaB signaling: AEBP1 is a novel proinflammatory mediator in macrophages Heparin: Past, Present, and Future Transmembrane Protein 184A Is a Receptor Required for Vascular Smooth Muscle Cell Responses to Heparin Low anticoagulant heparin targets multiple sites of inflammation, suppresses heparin-induced thrombocytopenia, and inhibits interaction of RAGE with its ligands.Stepwise inhibition of T cell recruitment at post-capillary venules by orally active desulfated heparins in inflammatory arthritis Nonanticoagulant heparin reduces myocyte Na+ and Ca2+ loading during simulated ischemia and decreases reperfusion injury.Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling.Clinical review: anticoagulation for continuous renal replacement therapy--heparin or citrate?Polyphosphate elicits pro-inflammatory responses that are counteracted by activated protein C in both cellular and animal models.Heparin reduces neuroinflammation and transsynaptic neuronal apoptosis in a model of subarachnoid hemorrhage.Effect of N-desulfated heparin on hepatic/renal ischemia reperfusion injury in rats Heparin Decreases in Tumor Necrosis Factor α (TNFα)-induced Endothelial Stress Responses Require Transmembrane Protein 184A and Induction of Dual Specificity Phosphatase 1.Heparin and LPS-induced COX-2 expression in airway cells: a link between its anti-inflammatory effects and GAG sulfation.The non-anticoagulant heparin-like K5 polysaccharide derivative K5-N,OSepi attenuates myocardial ischaemia/reperfusion injury Role of tumour necrosis factor-alpha and other cytokines in ischemia-reperfusion-induced injury in the heart.Effects of heparin and related molecules upon neutrophil aggregation and elastase release in vitro.Systemic administration of heparin ameliorates radiation-induced oral mucositis-preclinical studies in mice.

P2860

Q21296830-43AA65B5-C63C-47DB-9411-B5C25369BD2D Q26744227-20AA9F4E-23F0-4F51-B9D4-E00CCA03ABA0 Q28567433-7609DD9B-8C0A-4387-A3BE-2EB948283C68 Q33389069-76EDE45A-922B-41B1-BEAC-6103FF83050A Q33574588-4414DAD6-8C26-4ADA-B6E2-97892F0872CF Q33589221-F7FD973E-1539-42B1-B648-CEAF1300E486 Q34960679-CAEB7106-9CB4-4E4C-B58E-10A2A02640C4 Q35567100-8B3995D2-42A2-4CEF-8903-F2A7635C4875 Q36003987-3DF73483-0CB8-4358-BE47-AFB57852E595 Q36025124-6AB6FD45-98CF-4A0E-80FF-BC32A19754A2 Q36309004-3B4A708A-F941-482D-BE3D-0DA1E31B984C Q36650401-C3EEA786-76C4-4D31-87B7-ED07543F6671 Q37129696-65703DB9-0790-4717-AE57-7523CD99EAE1 Q37294940-3244ACDC-63E5-487F-82B6-2D14AD4A8A21 Q41824383-15E56178-B257-4274-9032-8FC2EBA2C8EE Q41935530-5F0BFF93-ED07-43F0-84BC-CB3163FEEADE Q52584133-1DA43735-2D71-425F-8A49-368F2A0352E9

P2860

Nonanticoagulant heparin inhibits NF-kappaB activation and attenuates myocardial reperfusion injury.

http://www.wikidata.org/entity/Q31393590

description

2000 nî lūn-bûn

@nan

2000 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Nonanticoagulant heparin inhib ...... myocardial reperfusion injury.

@ast

Nonanticoagulant heparin inhib ...... myocardial reperfusion injury.

@en

type

label

Nonanticoagulant heparin inhib ...... myocardial reperfusion injury.

@ast

Nonanticoagulant heparin inhib ...... myocardial reperfusion injury.

@en

prefLabel

Nonanticoagulant heparin inhib ...... myocardial reperfusion injury.

@ast

Nonanticoagulant heparin inhib ...... myocardial reperfusion injury.

@en

P1433

Q31393590-14E29474-4BEC-4323-91AD-E1D07ED0A6EF

P1476

Q31393590-A523C177-7C6E-4747-9467-89DBFA93B018

P2093

Q31393590-05789D17-40D9-4284-954A-569202A21230

Q31393590-0A9F0A11-EBF9-4CBE-9335-45D5D3100146

Q31393590-2CA65357-BF78-4A1E-B320-AEE08C3C5D1D

Q31393590-3047A533-608B-4104-9374-5BB702D2CFAC

Q31393590-3370026B-E6C1-493D-A0E1-C9C83ABD5C6D

Q31393590-5F75AC9E-935E-4BAB-B815-F19A24FF8C57

Q31393590-A04AE0F9-3D17-45FA-B385-CEA2A6EF6CF9

Q31393590-DD83B4B2-FB98-4FBE-9BD8-75E4D8BF4549

Q31393590-DFAC7867-A0F2-43A1-AC7B-594D14D36CCB

Q31393590-F14C89EE-A9D4-4434-A678-7E446131BC84

P2860

Q31393590-0F81B0FA-6F37-4B17-9745-082A03A3DE34

Q31393590-2948F33C-9FD1-48F7-9BE2-8DA1DE3F6F99

Q31393590-324F0C9C-61F9-4DAF-9AF9-89BEDD8D8E56

Q31393590-627F366A-2C88-4288-B3A4-B0A8541C0167

Q31393590-66A15DFB-5F58-4470-8326-8836ADE48832

Q31393590-A568944B-0D0D-4041-9901-8B3F4947991C

Q31393590-A9BB1BAE-C159-4F45-B97B-0EBF6537C121

Q31393590-ACD84D20-23C1-45FE-B6C0-66AB323ACDC5

Q31393590-BA3654D8-EE79-4B52-B351-0BA897CCC4C8

Q31393590-BD35F73C-06C8-4CBE-877A-3A8AB1612E76

P304

Q31393590-E5BC9002-1464-4D3A-84E7-34E5F18FD7FF

P31

Q31393590-A4FF439B-24EF-4499-9429-D3A855990E22

P356

Q31393590-1B513BA7-BC8F-425F-820B-D129B1F0570E

P433

Q31393590-31C6297D-BA77-4FDF-97FF-40CC024378FC

P478

Q31393590-AFFB1E54-92AE-4F8A-AA2C-E75FB331ADBA

P577

Q31393590-C59C8125-9249-468C-952F-CB1B96535803

P698

Q31393590-FC01AA3E-12BE-493A-B14D-909F2C7C2ACB

P921

Q31393590-B922B612-B419-4214-B68F-5BC1603C7D05

P356

AJPHEART.2000.278.6.H2084

P1433

American Journal of Physiology - Heart and Circulatory Physiology

P1476

Nonanticoagulant heparin inhib ...... myocardial reperfusion injury.

@en

P2093

Brar SS

http://www.w3.org/2001/XMLSchema#string

Hoidal JR

http://www.w3.org/2001/XMLSchema#string

Kennedy TP

http://www.w3.org/2001/XMLSchema#string

Ronson RS

http://www.w3.org/2001/XMLSchema#string

Sturrock AL

http://www.w3.org/2001/XMLSchema#string

Thornton LR

http://www.w3.org/2001/XMLSchema#string

Thourani VH

http://www.w3.org/2001/XMLSchema#string

Vinten-Johansen J

http://www.w3.org/2001/XMLSchema#string

Watts JA

http://www.w3.org/2001/XMLSchema#string

Zhao ZQ

http://www.w3.org/2001/XMLSchema#string

P2860

Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei

Ikappa Balpha functions through direct contacts with the nuclear localization signals and the DNA binding sequences of NF-kappaB

Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane

Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria

NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control

Therapeutic strategies to reduce TNF-alpha mediated cardiac contractile depression following ischemia and reperfusion.

Dermatan sulfate activates nuclear factor-kappab and induces endothelial and circulating intercellular adhesion molecule-1.

Interleukin-8 gene induction in the myocardium after ischemia and reperfusion in vivo.

Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence.

Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents.

P304

H2084-93

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPHEART.2000.278.6.H2084

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

278

http://www.w3.org/2001/XMLSchema#string

P577

2000-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10843908

http://www.w3.org/2001/XMLSchema#string

P921

reperfusion injury